GlaxoSmithKline
GSK
#212
Rank
โ‚ฌ83.82 B
Marketcap
41,50ย โ‚ฌ
Share price
2.41%
Change (1 day)
25.83%
Change (1 year)

GlaxoSmithKline (GSK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ52.53 Billion

According to GlaxoSmithKline's latest financial reports the company's total liabilities are โ‚ฌ52.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlaxoSmithKline - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ55.92 B5.02%
2023-12-31โ‚ฌ53.25 B-5.66%
2022-12-31โ‚ฌ56.44 B-18.01%
2021-12-31โ‚ฌ68.84 B4.2%
2020-12-31โ‚ฌ66.07 B-7.97%
2019-12-31โ‚ฌ71.79 B18.96%
2018-12-31โ‚ฌ60.35 B1.31%
2017-12-31โ‚ฌ59.57 B-6.16%
2016-12-31โ‚ฌ63.48 B5.1%
2015-12-31โ‚ฌ60.40 B32.12%
2014-12-31โ‚ฌ45.71 B11.68%
2013-12-31โ‚ฌ40.93 B-3.57%
2012-12-31โ‚ฌ42.45 B9.98%
2011-12-31โ‚ฌ38.60 B2.39%
2010-12-31โ‚ฌ37.70 B3.92%
2009-12-31โ‚ฌ36.27 B11.36%
2008-12-31โ‚ฌ32.57 B13.4%
2007-12-31โ‚ฌ28.72 B21.71%
2006-12-31โ‚ฌ23.60 B-17.37%
2005-12-31โ‚ฌ28.56 B22.39%
2004-12-31โ‚ฌ23.33 B6.05%
2003-12-31โ‚ฌ22.00 B-3.95%
2002-12-31โ‚ฌ22.91 B2.86%
2001-12-31โ‚ฌ22.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
โ‚ฌ58.70 B 11.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ99.12 B 88.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ66.55 B 26.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ53.60 B 2.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ56.59 B 7.74%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚ฌ27.94 B-46.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.35 B-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA